Closely held Pipeline Therapeutics named Evert (Eef) Schimmelpennink to its board. Mr. Schimmelpennink is a seasoned biotechnology executive with close to 25 years of experience spanning research and development...

In-network psychiatric care provider, Talkiatry, appointed Vanessa Cao as SVP of operations as the company prepares for a national rollout. With more than 10 years of experience in operations, Ms. Cao joins Talkiatry...

Closely held Labster, a virtual learning platform for students, named Hope Frank as chief marketing officer as part of its continued mission to bring accessible and transformative STEM education (science, technology...

Closely held cell therapy manufacturer, Cellares, appointed Ezekiel Emanuel, M.D. and Ph.D., to its board of advisors. Dr. Emanuel is a bioethicist and currently vice provost for global initiatives, the Diane and Robert...

Closely held GeneTether, a genome editing technology company, named Roland Boivin as CEO, Jean Jen as CFO and Peter Sampson, Ph.D., as VP of research and development.  The appointments are intended to further position...

Kyle Mikson Canaccord Genuity appointed Kyle Mikson as a director, senior equity research analyst covering the life science tools and diagnostics sector.  Mr. Mikson will focus on expanding the firm’s footprint on...

Adam Cutler Closely-held Q32 Bio appointed Adam Cutler as chief financial officer, with responsibility for all aspects of its financial strategy and operations. Mr. Cutler has more than 20 years of experience in...

Closely held Talkiatry, a leading mental health care provider that connects people with high-quality psychiatric care via telehealth or in-person, appointed Jared Camins as chief technology officer.

Eric Tansky, former managing director in Oppenheimer’s medical technology practice, has joined Accelmed Partners, a private equity firm in HealthTech, as a general partner, and Stephen Rubin, former co-head of...

Doug Kleinberg Doug Kleinberg has joined BTIG’s healthcare investment banking unit as a managing director to focus on investment banking opportunities for corporate clients across biotech, biopharma and pharma.  Mr...

John Boris John Boris has joined Roth Capital Partners’ healthcare investment banking team as a managing director. Prior to joining Roth, Mr. Boris was the managing partner of JTB Capital Management, where he invested...